WO2004035732A3 - Human polypeptides encoded by polynucleotides and methods of their use - Google Patents

Human polypeptides encoded by polynucleotides and methods of their use Download PDF

Info

Publication number
WO2004035732A3
WO2004035732A3 PCT/US2003/026780 US0326780W WO2004035732A3 WO 2004035732 A3 WO2004035732 A3 WO 2004035732A3 US 0326780 W US0326780 W US 0326780W WO 2004035732 A3 WO2004035732 A3 WO 2004035732A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
polynucleotides
modulators
compositions
polypeptides encoded
Prior art date
Application number
PCT/US2003/026780
Other languages
French (fr)
Other versions
WO2004035732A2 (en
Inventor
Lewis T Williams
Keting Chu
Ernestine Lee
Kevin Hestir
Pierre Alvaro Beaurang
Dirk Behrens
Robert Forgan Halenbeck
Min Mei Huang
Srinivas Kothakota
Lin Haishan
Thomas Linnemann
Kristen Pierce
Yan Wang
Justin G P Wong
Ge Wu
Hongbing Zhang
Original Assignee
Five Prime Therapeutics Inc
Lewis T Williams
Keting Chu
Ernestine Lee
Kevin Hestir
Pierre Alvaro Beaurang
Dirk Behrens
Robert Forgan Halenbeck
Min Mei Huang
Srinivas Kothakota
Lin Haishan
Thomas Linnemann
Kristen Pierce
Yan Wang
Justin G P Wong
Ge Wu
Hongbing Zhang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Five Prime Therapeutics Inc, Lewis T Williams, Keting Chu, Ernestine Lee, Kevin Hestir, Pierre Alvaro Beaurang, Dirk Behrens, Robert Forgan Halenbeck, Min Mei Huang, Srinivas Kothakota, Lin Haishan, Thomas Linnemann, Kristen Pierce, Yan Wang, Justin G P Wong, Ge Wu, Hongbing Zhang filed Critical Five Prime Therapeutics Inc
Priority to AU2003294217A priority Critical patent/AU2003294217A1/en
Publication of WO2004035732A2 publication Critical patent/WO2004035732A2/en
Publication of WO2004035732A3 publication Critical patent/WO2004035732A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides novel polynucleotides, related polypeptides related nucleic acid and polypeptide compositions, and related modulators, such as antibodies and small molecule modulators. The invention also provides methods to make and use these polynucleotides, polypeptides, related compositions, and modulators. These methods include diagnostic, prophylactic and therapeutic applications. The compositions and methods of the invention are useful in treating proliferative disorders, e.g., cancers, and inflammatory, immune, bacterial, and viral disorders.
PCT/US2003/026780 2002-08-29 2003-08-28 Human polypeptides encoded by polynucleotides and methods of their use WO2004035732A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003294217A AU2003294217A1 (en) 2002-08-29 2003-08-28 Human polypeptides encoded by polynucleotides and methods of their use

Applications Claiming Priority (135)

Application Number Priority Date Filing Date Title
US40664602P 2002-08-29 2002-08-29
US40661202P 2002-08-29 2002-08-29
US40661102P 2002-08-29 2002-08-29
US40657902P 2002-08-29 2002-08-29
US40658802P 2002-08-29 2002-08-29
US40665502P 2002-08-29 2002-08-29
US40660802P 2002-08-29 2002-08-29
US40665302P 2002-08-29 2002-08-29
US40664202P 2002-08-29 2002-08-29
US40661602P 2002-08-29 2002-08-29
US40658502P 2002-08-29 2002-08-29
US40666602P 2002-08-29 2002-08-29
US40657602P 2002-08-29 2002-08-29
US40664002P 2002-08-29 2002-08-29
US60/406,576 2002-08-29
US60/406,640 2002-08-29
US60/406,616 2002-08-29
US60/406,655 2002-08-29
US60/406,646 2002-08-29
US60/406,579 2002-08-29
US60/406,585 2002-08-29
US60/406,653 2002-08-29
US60/406,608 2002-08-29
US60/406,642 2002-08-29
US60/406,611 2002-08-29
US60/406,588 2002-08-29
US60/406,666 2002-08-29
US60/406,612 2002-08-29
US41095302P 2002-09-17 2002-09-17
US41102202P 2002-09-17 2002-09-17
US41104502P 2002-09-17 2002-09-17
US41103702P 2002-09-17 2002-09-17
US41105502P 2002-09-17 2002-09-17
US41110102P 2002-09-17 2002-09-17
US41104102P 2002-09-17 2002-09-17
US41107302P 2002-09-17 2002-09-17
US41096202P 2002-09-17 2002-09-17
US41094902P 2002-09-17 2002-09-17
US41111102P 2002-09-17 2002-09-17
US41104602P 2002-09-17 2002-09-17
US41108202P 2002-09-17 2002-09-17
US41102402P 2002-09-17 2002-09-17
US41104802P 2002-09-17 2002-09-17
US41094802P 2002-09-17 2002-09-17
US41094702P 2002-09-17 2002-09-17
US41094602P 2002-09-17 2002-09-17
US41103502P 2002-09-17 2002-09-17
US41095902P 2002-09-17 2002-09-17
US41095702P 2002-09-17 2002-09-17
US41095802P 2002-09-17 2002-09-17
US41101902P 2002-09-17 2002-09-17
US41102302P 2002-09-17 2002-09-17
US41105202P 2002-09-17 2002-09-17
US41096102P 2002-09-17 2002-09-17
US41096002P 2002-09-17 2002-09-17
US60/411,055 2002-09-17
US60/410,959 2002-09-17
US60/411,037 2002-09-17
US60/410,953 2002-09-17
US60/410,958 2002-09-17
US60/411,035 2002-09-17
US60/411,045 2002-09-17
US60/411,101 2002-09-17
US60/411,023 2002-09-17
US60/411,111 2002-09-17
US60/410,960 2002-09-17
US60/410,946 2002-09-17
US60/410,949 2002-09-17
US60/410,961 2002-09-17
US60/411,022 2002-09-17
US60/411,019 2002-09-17
US60/411,082 2002-09-17
US60/410,962 2002-09-17
US60/411,073 2002-09-17
US60/411,041 2002-09-17
US60/410,948 2002-09-17
US60/411,032 2002-09-17
US60/411,024 2002-09-17
US60/411,046 2002-09-17
US60/410,957 2002-09-17
US60/410,947 2002-09-17
US60/411,052 2002-09-17
US60/411,048 2002-09-17
US46371603P 2003-04-18 2003-04-18
US46373203P 2003-04-18 2003-04-18
US46370803P 2003-04-18 2003-04-18
US46370003P 2003-04-18 2003-04-18
US60/463,716 2003-04-18
US60/463,708 2003-04-18
US60/463,732 2003-04-18
US60/463,700 2003-04-18
US46720103P 2003-05-02 2003-05-02
US46720303P 2003-05-02 2003-05-02
US46719903P 2003-05-02 2003-05-02
US46723003P 2003-05-02 2003-05-02
US60/467,203 2003-05-02
US60/467,199 2003-05-02
US60/467,230 2003-05-02
US60/467,201 2003-05-02
US47130603P 2003-05-19 2003-05-19
US47133603P 2003-05-19 2003-05-19
US60/471,306 2003-05-19
US60/471,336 2003-05-19
US47243003P 2003-05-22 2003-05-22
US47242003P 2003-05-22 2003-05-22
US60/472,430 2003-05-22
US60/472,420 2003-05-22
US47664103P 2003-06-09 2003-06-09
US47660903P 2003-06-09 2003-06-09
US60/476,641 2003-06-09
US60/476,609 2003-06-09
US48522303P 2003-07-08 2003-07-08
US48522403P 2003-07-08 2003-07-08
US48521803P 2003-07-08 2003-07-08
US48532503P 2003-07-08 2003-07-08
US60/485,224 2003-07-08
US60/485,218 2003-07-08
US60/485,223 2003-07-08
US60/485,325 2003-07-08
US48644603P 2003-07-14 2003-07-14
US48648003P 2003-07-14 2003-07-14
US60/486,446 2003-07-14
US60/486,480 2003-07-14
US48689103P 2003-07-15 2003-07-15
US48696003P 2003-07-15 2003-07-15
US60/486,891 2003-07-15
US60/486,960 2003-07-15
US49357303P 2003-08-08 2003-08-08
US49357703P 2003-08-08 2003-08-08
US49337003P 2003-08-08 2003-08-08
US49334103P 2003-08-08 2003-08-08
US60/493,370 2003-08-08
US60/493,577 2003-08-08
US60/493,573 2003-08-08
US60/493,341 2003-08-08

Publications (2)

Publication Number Publication Date
WO2004035732A2 WO2004035732A2 (en) 2004-04-29
WO2004035732A3 true WO2004035732A3 (en) 2006-01-26

Family

ID=37714949

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/026780 WO2004035732A2 (en) 2002-08-29 2003-08-28 Human polypeptides encoded by polynucleotides and methods of their use

Country Status (2)

Country Link
AU (1) AU2003294217A1 (en)
WO (1) WO2004035732A2 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0401730D0 (en) 2004-01-27 2004-03-03 Bioxell Spa Diagnosis method
ATE430763T1 (en) * 2004-03-30 2009-05-15 Nsgene As THERAPEUTIC USE OF GROWTH FACTOR NSG33
WO2005101004A2 (en) * 2004-04-13 2005-10-27 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1)
EP1768997A1 (en) 2004-07-12 2007-04-04 CropDesign N.V. Plants having improved growth characteristics and method for making the same
EP1627922A1 (en) * 2004-08-18 2006-02-22 Sanofi-Aventis Deutschland GmbH Method of screening for a carnitine transporter agonist or antagonist and its uses
EP2221316A1 (en) 2005-05-05 2010-08-25 Duke University Anti-CD19 antibody therapy for autoimmune disease
US7354904B2 (en) * 2005-12-08 2008-04-08 The United States Of America As Represented By The Secretary Of Agriculture Bacteriocin inducer peptides
AU2007269786A1 (en) * 2006-06-30 2008-01-10 Discoverx Corporation Detectable nucleic acid tag
WO2008097439A2 (en) * 2007-02-07 2008-08-14 The Trustees Of The University Of Pennsylvania Anti-autoimmune antibodies for treatment of pemphigus
AU2008290060B2 (en) * 2007-08-20 2014-04-24 Oncotherapy Science, Inc. CDH3 peptide and medicinal agent comprising the same
GB0803352D0 (en) * 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
AU2009273600B2 (en) 2008-07-24 2013-04-18 Hoba Therapeutics Aps Therapeutic use of a growth factor, METRNL
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
CA2759211C (en) 2009-04-24 2017-02-28 Daniel Kelly Treiber Assay for detecting protein by a cellular process
WO2011063152A1 (en) 2009-11-18 2011-05-26 Affinergy, Inc. Methods and compositions for soft tissue repair
CN103269708A (en) 2010-10-01 2013-08-28 Ns基因公司 Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
JP6145667B2 (en) 2011-09-05 2017-06-14 ホーバ セラピューティクス アンパルトセルスカブ Treatment of allodynia, hyperalgesia, spontaneous pain, and phantom pain
WO2014071200A1 (en) * 2012-11-02 2014-05-08 The Regents Of The University Of Colorado, A Body Corporate Beta blocker responder status assays and related materials and methods
WO2014141064A1 (en) 2013-03-13 2014-09-18 Novartis Ag Notch2 binding molecules for treating respiratory diseases
EP3083676B1 (en) 2013-12-20 2019-08-28 Novartis AG Novel eukaryotic cells and methods for recombinantly expressing a product of interest
SG11201604218RA (en) 2013-12-20 2016-07-28 Novartis Ag Novel eukaryotic cells and methods for recombinantly expressing a product of interest
EP2899205A1 (en) * 2014-01-23 2015-07-29 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Interaction of Draxin and y-Netrins
EP3215538A4 (en) 2014-11-07 2018-07-04 Igenica Biotherapeutics, Inc. Anti-cd39 antibodies and uses thereof
WO2022136440A1 (en) * 2020-12-21 2022-06-30 Syngenta Crop Protection Ag Pesticidal hexatoxin polypeptides and methods of use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CANAVEZ F. ET AL: "Comparison of chimpanzee anf human leukocyte Ig-like receptor genes reveals framework and rapidly evolving genes", J. IMMUNOL., vol. 167, no. 10, 2001, pages 5786 - 2794, XP002993003 *

Also Published As

Publication number Publication date
AU2003294217A1 (en) 2004-05-04
AU2003294217A8 (en) 2004-05-04
WO2004035732A2 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
WO2004035732A3 (en) Human polypeptides encoded by polynucleotides and methods of their use
WO2004020595A8 (en) Novel human polypeptides encoded by polynucleotides
WO2004000997A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2004093804A3 (en) Human polypeptides encoded by polynucleotides and methods of their use
WO2002055705A3 (en) Proteins and nucleic acids encoding same
WO2002068649A3 (en) Proteins and nucleic acids encoding same
WO2002081518A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2001090155A3 (en) Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
WO2004094651A3 (en) Novel human polypeptides encoded by polynucleotides
WO2002068652A3 (en) Nov-x proteins and nucleic acids encoding same
WO2004020591A3 (en) Methods of use for novel human polypeptides encoded by polynucleotides
WO2004038003A3 (en) Human polypeptides encoded by polynucleotides and methods of their use
WO2002055704A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2002081510A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2005085280A3 (en) HUMAN cDNA CLONES COMPRISING POLYNUCLEOTIDES ENCODING POLYPEPTIDES AND METHODS OF THEIR USE
WO2003029423A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2004039952A3 (en) Methods of use for novel human polypeptides encoded by polynucleotides
WO2003022998A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003078572A3 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
WO2003031571A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2004046310A3 (en) Novel mouse polypeptides encoded by polynucleotides and methods of their use
WO2003040329A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2004094598A3 (en) Methods of use for novel human polypeptides encoded by polynucleotides
WO2003085124A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2005005597A3 (en) Novel mouse polypeptides encode by polynucleotides and methods of their use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP